Albemarle (ALB) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 net sales were $1.4–$1.43 billion, down 40% year-over-year due to lower lithium pricing, partially offset by 37% volume growth in Energy Storage as new capacity ramped up.
Net loss attributable to shareholders was $188 million, or $(1.96) per diluted share, including a $215 million after-tax charge for asset write-offs and contract cancellations.
Adjusted EBITDA was $375–$386 million, down 69–70% year-over-year but up sequentially, driven by higher Talison JV sales and productivity actions.
Over $150 million in productivity and restructuring benefits delivered in Q2, with a comprehensive cost and operating review underway, including immediate changes at Kemerton.
Announced further restructuring in July 2024, including stopping construction of Kemerton Train 3, placing Train 2 into care and maintenance, and expecting a Q3 2024 charge of $0.9–$1.1 billion.
Financial highlights
Net sales declined to $1.4–$1.43 billion from $2.4 billion in Q2 2023, primarily due to a 53% drop in Energy Storage sales from lower pricing.
Adjusted diluted EPS was $0.04; adjusted EBITDA margin was 26.2–27% in Q2 2024.
Cash from operations reached $362.9–$363 million, up $289 million year-over-year, with operating cash conversion at 94%.
Available liquidity at quarter-end was $3.5 billion, including $1.8 billion in cash and $1.5 billion undrawn revolver.
Net debt to adjusted EBITDA was 2.1x, well below covenant maximums.
Outlook and guidance
Full-year 2024 outlook maintained, with net sales expected at $5.5–$6.8 billion and adjusted EBITDA at $0.9–$1.8 billion, assuming $15/kg lithium price scenario.
Energy Storage volumes projected to increase 10–20% year-over-year in 2024; sequential growth expected to moderate in the second half.
CapEx for 2024 expected at the high end of $1.7–$1.8 billion, with further reductions under evaluation.
Specialties adjusted EBITDA outlook reduced due to higher logistics and raw material costs and slower market rebound.
Additional restructuring actions may be required if lithium prices remain low for an extended period.
Latest events from Albemarle
- Annual meeting features director elections, compensation votes, and key governance proposals.ALB
Proxy filing24 Mar 2026 - Disciplined execution, governance reforms, and pay-for-performance drive 2025 results.ALB
Proxy filing24 Mar 2026 - FY 2025 delivered robust growth, cost savings, and strong cash flow amid rising lithium demand.ALB
Investor presentation11 Mar 2026 - 2025 saw robust financial results, governance enhancements, and major compensation and ESG updates.ALB
Proxy Filing11 Mar 2026 - Q4 sales up 16% YoY, strong cash flow, cost actions, and positive 2026 outlook despite net loss.ALB
Q4 202512 Feb 2026 - Q3 net loss of $1.07–$1.1B on 41% lower sales; 2025 capex to be halved amid cost actions.ALB
Q3 202416 Jan 2026 - Lithium market faces oversupply, low prices, and consolidation, but demand growth remains strong.ALB
9th Annual Lithium and Battery Supply Chain Conference11 Jan 2026 - 2024 saw sharp sales decline, cost actions, and a path to breakeven free cash flow in 2025.ALB
Q4 202429 Dec 2025 - Q1 2025 saw resilient EBITDA and cost discipline despite lower lithium prices and sales.ALB
Q1 202522 Dec 2025